Cytek Biosciences, Inc.
CTKB • NASDAQ
Cytek Biosciences, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Wenbin Jiang, with a market cap of $593.9M.
Market Cap$593.9M
Employees637.0
CEOWenbin Jiang
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Cytek Biosciences, Inc. FAQ
Common questions about Cytek Biosciences, Inc.
Cytek Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $43.8M.
Cytek Biosciences, Inc. has approximately 637 employees.